Li Li
Founder presso SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
Patrimonio netto: 686 M $ in data 31/03/2024
Profilo
Li Li è un uomo d'affari che ha fondato la Shenzhen Hepalink Pharmaceutical Group Co., Ltd. e che è stato a capo di 5 diverse aziende. Attualmente ricopre la posizione di presidente della Shenzhen Techdow Pharmaceutical Co., Ltd. e di presidente della Shenzhen Hepalink Pharmaceutical Group Co., Ltd., presidente e amministratore delegato della Hepalink USA, Inc. e presidente della Shenzhen Duopule Industrial Development Co. (entrambe sono filiali di Shenzhen Hepalink Pharmaceutical Group Co., Ltd.). Fa anche parte del consiglio di amministrazione di Cytovance Biologics, Inc. (ex presidente), Shenzhen Leren Technology Co. Ltd. e Urumqi Feilaishi Equity Investment Co. Ltd. Il signor Li si è laureato presso l'Università di Sichuan.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 30/06/2023 | 514 349 899 ( 41.24% ) | 594 M $ | 31/03/2024 | |
HIGHTIDE THERAPEUTICS INC
23.61% | 02/02/2024 | 121 515 210 ( 23.61% ) | 92 M $ | 31/03/2024 |
Posizioni attive di Li Li
| Società | Posizione | Inizio |
|---|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Founder | 21/04/1998 |
Shenzhen Leren Technology Co. Ltd.
 Shenzhen Leren Technology Co. Ltd. Information Technology ServicesTechnology Services Shenzhen Leren Technology Co. Ltd. is a Chinese company that engages in technology development. | Director/Board Member | - |
| Urumqi Feilaishi Equity Investment Co. Ltd. | Director/Board Member | - |
| Shenzhen Techdow Pharmaceutical Co., Ltd. | Chairman | - |
Hepalink USA, Inc.
 Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Hepalink USA, Inc. develops macromolecule biopharmaceutical products. The company offers scientific protein laboratories and active pharmaceutical ingredients. The company was founded in 1998 and is headquartered in Oak Brook, IL. | Chief Executive Officer | - |
Shenzhen Duopule Industrial Development Co., Ltd.
 Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Chairman | 13/01/2014 |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Director/Board Member | - |
| Shenzhen Arimab Biopharmaceuticals Co., Ltd. | Chairman | - |
Precedenti posizioni note di Li Li
| Società | Posizione | Fine |
|---|---|---|
| HIGHTIDE THERAPEUTICS, INC. | Director/Board Member | 02/02/2024 |
Formazione di Li Li
| Sichuan University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Health Technology |
| HIGHTIDE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
Shenzhen Leren Technology Co. Ltd.
Shenzhen Leren Technology Co. Ltd. Information Technology ServicesTechnology Services Shenzhen Leren Technology Co. Ltd. is a Chinese company that engages in technology development. | Technology Services |
| Urumqi Feilaishi Equity Investment Co. Ltd. | |
| Shenzhen Techdow Pharmaceutical Co., Ltd. | |
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Hepalink USA, Inc. develops macromolecule biopharmaceutical products. The company offers scientific protein laboratories and active pharmaceutical ingredients. The company was founded in 1998 and is headquartered in Oak Brook, IL. | Health Technology |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Distribution Services |
| Shenzhen Arimab Biopharmaceuticals Co., Ltd. |
- Borsa valori
- Insiders
- Li Li
